陈启明2025年二季度表现，华富天鑫灵活配置混合A基金季度涨幅0.92%

Core Viewpoint - Fund manager Chen Qiming has managed two funds as of the end of Q2 2025, with the best-performing fund being Huafu Tianxin Flexible Allocation Mixed A (003152), which achieved a net value increase of 0.92% in the quarter [1]. Fund Performance Summary - Chen Qiming's managed funds include: - Huafu Dacai Flexible Allocation Mixed C (003153) with an annualized return of 5.68% and a Q2 increase of 0.70%, holding a major stock, Xuguang Electronics (600353.SH), at 7.23% of net value [2]. - Huafu Daxin Flexible Allocation Mixed A (003152) with an annualized return of 6.53% and a Q2 increase of 0.92%, also holding Xuguang Electronics at 7.23% of net value [2]. - During his tenure managing Huafu Value Growth Mixed A (410007), Chen achieved a cumulative return of 232.74% with an average annualized return of 11.77%, executing 96 stock adjustments with a success rate of 63.54% [2]. Stock Adjustment Cases - Notable stock adjustment cases managed by Chen Qiming include: - Boteng Co., Ltd. (300363) was bought in Q2 2018 and sold in Q3 2022, yielding an estimated return of 396.40% with a company performance growth of 1510.87% during the holding period [5]. - Yifeng Pharmacy (603939) was bought in Q2 2016 and sold in Q2 2019, yielding an estimated return of 96.12% with a company performance growth of 175.23% during the holding period [6]. - Beilu Pharmaceutical (300016) was bought in Q2 2015 and sold in Q1 2017, resulting in a loss of -59.25% despite a company performance growth of 264.70% during the holding period [7].